MDD Augmentation: Lithium

We continue our lecture series “10 Augmentation Strategies for MDD” with our second lecture on the role of lithium as an augmentation for major depressive disorder (MDD).

Lithium is the only medication to be recommended by most guidelines for depression augmentation treatment and this is one of the most studied medication for this indication. For this reason, it is clinically relevant for medical professionals to have a detailed knowledge of this clinically relevant topic. 

Let’s begin with this question:

Lithium augmentation should be maintained in the lithium-antidepressant combination for how long after remission is achieved?

Answer: 1 Year

Here is one slide from this presentation explaining the answer

The role of Lithium for MDD augmentation will be discussed in the following sections:

CHAPTER 2: LITHIUM FOR MDD AUGMENTATION

(FOR ACADEMY MEMBERS ONLY)
members only

INTERESTED IN LEARNING MORE?

JOIN ACADEMY’S FIRST LECTURE SERIES OF 2023:

PSYCHIATRY EDUCATION FORUM ACADEMY'S
JANUARY 2023 LECTURE SERIES ANNOUNCEMENT
(JAN 14 - JAN 29, 2023)

MAJOR DEPRESSIVE DISORDER:
10 AUGMENTATION STRATEGIES

Major Depressive Disorder: 10 Augmentation Strategies

JOIN HERE

JOIN ACADEMY MEMBERSHIP:

GENERAL
$ 99/YR
  •  
STUDENTS
$ 75/YR
  •  

DISCOUNTS AVAILABLE FOR: Residents & Students ONLY.

Email us your student information (program information and way to confirm your student status) to: HSingh@PsychiatryEducationForum.com

Related Articles

Responses

Your email address will not be published. Required fields are marked *